tirzepatide news october 18 2025 📣 BIG IN OBESITY MEDICINE! 🇨🇦 Health Canada has officially approved Zepbound™ KwikPen® (tirzepatide injection) for chronic weight management! Zepbound™ is a once-weekly injectable medication that works by activating two key Tirzepatide shows 98.7% diabetes prevention

Choi suggests that people interested in lowering or stopping their dosage should follow the same approach as those starting a weight-loss medication work with a doctor

It carries a C20 fatty-diacid acylation that enables strong albumin binding and a serum half-life of approximately 6 days, supporting the once-weekly administration cadence used in published Phase 2 research literature

If you are experiencing lower back pain while taking semaglutide, it is essential to consult with your healthcare provider to discuss your symptoms and explore possible solutions

Additionally, some patients report altered taste

This represents a significant consideration for healthcare providers and patients making treatment decisions